Castlight health, inc. (CSLT)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12
Revenue:
Total revenue, net

143,308

156,404

132,020

98,708

-

-

-

-

Subscription

-

-

-

-

70,350

41,602

11,655

3,395

Professional services and other

-

-

-

-

4,965

4,003

1,318

759

Total revenue, net

-

-

-

-

75,315

45,605

12,973

4,154

Cost of revenue:
Total cost of revenue

59,074

60,189

46,652

31,866

-

-

-

-

Cost of subscription

-

-

-

-

12,417

10,472

6,246

3,242

Cost of professional services

-

-

-

-

21,351

17,300

11,058

5,286

Total cost of revenue

-

-

-

-

33,768

27,772

17,304

8,528

Gross profit

84,234

96,215

85,368

66,842

41,547

17,833

-4,331

-4,374

Operating expenses:
Sales and marketing

38,597

49,134

59,767

58,641

67,414

62,065

33,742

15,829

Research and development

58,994

61,355

54,502

40,460

30,077

22,917

15,219

9,718

General and administrative

27,981

25,620

28,825

26,859

24,274

19,009

9,047

5,212

Total operating expenses

125,572

136,109

143,094

125,960

121,765

103,991

58,008

30,759

Operating loss

-41,338

-39,894

-57,726

-59,118

-80,218

-86,158

-62,339

-35,133

Other income, net

1,336

188

618

432

298

218

157

129

Loss before income tax benefit

-40,000

-39,700

-57,100

-58,686

-79,920

-

-

-

Income tax benefit

0

0

-5,206

0

0

-

-

-

Net loss

-40,002

-39,706

-51,902

-58,686

-79,920

-85,940

-62,182

-35,004

Net loss per share, basic and diluted (in usd per share)

-0.28

-0.29

-0.41

-0.58

-850.00

-1.16

-6.28

-4.44

Weighted-average shares used to compute basic and diluted net loss per share (in shares)

145,172

137,686

125,534

100,798

93,753

74,381

9,895

7,885

Subscription
Total revenue, net

137,393

143,901

121,368

91,943

-

-

-

-

Total cost of revenue

34,067

34,691

28,410

16,463

-

-

-

-

Professional services and other
Total revenue, net

5,915

12,503

10,652

6,765

-

-

-

-

Total cost of revenue

25,007

25,498

18,242

15,403

-

-

-

-